Trial intelligence / Profile preview

Imiquimod Adjunct to Cryotherapy for Actinic Keratosis

NCT00110682Phase 4Completed

Sponsor
DermResearch
Start
Apr 2005
Primary completion
Oct 2006
Modality
Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of imiquimod in actinic keratosis (AK), sponsored by DermResearch. Started Apr 2005; status: completed.

02

Drugs

imiquimod
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT00110682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00110682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call